Resultados da pesquisa - ((transl lung) OR (cranial lung)) ((cancer res) OR (cancer renal))

Pesquisas alternativas:
cranial lung » cranial bone (Expandir a Pesquisa), cranial dura (Expandir a Pesquisa)
transl lung » transoral lung (Expandir a Pesquisa), transl dunja (Expandir a Pesquisa)
cancer res » cancer re (Expandir a Pesquisa), cancer real (Expandir a Pesquisa), cancer read (Expandir a Pesquisa)

321

ALK and ROS1 as a joint target for the treatment of lung cancer: a review

ALK and ROS1 as a joint target for the treatment of lung cancer: a review

Por Puig de la Bellacasa, Raimon, Karachaliou, Niki, Estrada-Tejedor, Roger, Teixidó, Jordi, Costa, Carlota, Borrell, José I.
Publicado no Transl Lung Cancer Res (2013)

“..., including non-small cell lung cancer (NSCLC). ALK fusions have gain of function properties while activating...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

322

Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)

Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)

Por Bonanno, Laura
Publicado no Transl Lung Cancer Res (2013)

“...-small cell lung cancer (NSCLC) patients is the use of a platinum-based chemotherapy combination...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

323

Nestin servers as a promising prognostic biomarker in non-small cell lung cancer

Nestin servers as a promising prognostic biomarker in non-small cell lung cancer

Por Liu, Fang, Zhang, Yuan, Lu, Ming, Wang, Cong, Li, Qingbao, Gao, Yongsheng, Mu, Dianbin, Cao, Yan, Li, Miaomiao, Meng, Xiangjiao
Publicado no Am J Transl Res (2017)

“...Lung cancer is currently the leading cause of cancer-related death worldwide and it is important...”
Obter o texto integral
Obter o texto integral

Artigo

324

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Por Wu, Yi-Long, Wang, Chang-Li, Liao, Mei-Lin, Guan, Zhong-Zhen, Gao, Chen-Yan, Lu, Shun, Zhao, Ming-Fang, Wang, Jie, Liu, Xiao-Qing, Yang, Jin-Ji, Liang, Jun, Mao, Wei-Min, Han, Bao-Hui, Zhang, Xu-Chao, Song, Yong, Feng, Ji-Feng, Ma, Sheng-Lin, Wu, Gang, Zhou, Cai-Cun, Chen, Ke-Neng, Cheng, Ying, He, Yong, Chen, Chun, Wang, Qun, Lin, Ji-Zhen, Zhu, Bo, Liu, Yun-Peng, Hu, Yi, Qiao, Gui-Bin, Zhou, Qing, Song, Qi-Bin, Wu, Nan, Wu, Lin, Huang, Cheng, Fu, Xiao-Long, Xiong, Jian-Ping, Hu, Jie, Hu, Cheng-Ping, Chang, Jian-Hua, Zhao, Qiong, Zhao, Jun, Zhou, Peng-Hui, Ma, Zhi-Yong, Chen, Yuan, Zhang, He-Long, Yang, Fan, Wang, Jian-Jun, Pan, Yue-Yin, Yang, Xue-Ning, Fan, Yun, Liu, Zhe, Fan, Wen, Yang, Nong, Guan, Yan-Fang, Sun, Hao, Zhong, Wen-Zhao
Publicado no Transl Lung Cancer Res (2018)

“.... Regarding these challenges, the 2017 Chinese Lung Cancer Summit expert panel organized a forum on the 14th...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

325

Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells

Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells

Por Chen, Shuangshuang, Zhao, Shuang, Wang, Xinxing, Zhang, Luo, Jiang, Enze, Gu, Yuan, Shangguan, Anna Junjie, Zhao, Hong, Lv, Tangfeng, Yu, Zhenghong
Publicado no Transl Lung Cancer Res (2015)

“... cancer cell lines. CONCLUSIONS: Crocin significantly suppressed the proliferation of human lung...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

326

How are lung cancer risk perceptions and cigarette smoking related?—testing an accuracy hypothesis

How are lung cancer risk perceptions and cigarette smoking related?—testing an accuracy hypothesis

Por Chen, Lei-Shih, Kaphingst, Kimberly A., Tseng, Tung-Sung, Zhao, Shixi
Publicado no Transl Cancer Res (2016)

“... perception of developing lung cancer and cigarette smoking have been inconsistently reported among studies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

327

MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications

MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications

Por Zorzetto, Michele, Ferrari, Simona, Saracino, Laura, Inghilleri, Simona, Stella, Giulia M
Publicado no Transl Lung Cancer Res (2012)

“...Lung cancer is the leading cause of death for solid tumors worldwide with an annual mortality...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

328

Erlotinib in patients with advanced non-small-cell lung cancer: A meta-analysis

Erlotinib in patients with advanced non-small-cell lung cancer: A meta-analysis

Por Gao, Hui, Ding, Xin, Wei, Dong, Cheng, Peng, Su, Xiaomei, Liu, Huanyi, Aziz, Fahad, Wang, Daoyuan, Zhang, Tao
Publicado no Transl Lung Cancer Res (2012)

“... inhibitor with single-agent activity in patients with non–small-cell lung cancer (NSCLC). In this article...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

329

P41. Scedosporium apiospermum mycetoma in a lung cancer patient—case report

P41. Scedosporium apiospermum mycetoma in a lung cancer patient—case report

Por Alevizopoulos, Nektarios, Laskarakis, Apostolos, Vagdatlis, Theodoros, Ntalapera, Vasiliki, Skoula, Anna, Tegos, Theodoros, Argirakos, Theodoros, Margariti, Charis, Vaslamatzis, Michail
Publicado no Transl Lung Cancer Res (2014)

“... in a lung cancer patient host. METHODS AND RESULTS: A 72-year-old man was consecutively admitted in our...”
Obter o texto integral
Obter o texto integral

Artigo

330

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

Por Zhang, Wei, Girard, Luc, Zhang, Yu-An, Haruki, Tomohiro, Papari-Zareei, Mahboubeh, Stastny, Victor, Ghayee, Hans K., Pacak, Karel, Oliver, Trudy G., Minna, John D., Gazdar, Adi F.
Publicado no Transl Lung Cancer Res (2018)

Assuntos: “...Original Article on Small Cell Lung Cancer: New Models, Markers and Beyond...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

331

The “liquid biopsy” in non-small cell lung cancer – not quite ready for prime time use

The “liquid biopsy” in non-small cell lung cancer – not quite ready for prime time use

Por Qin, Angel, Ramnath, Nithya
Publicado no Transl Cancer Res (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

332

Editorial preface to this special issue “Improving the quality and outcomes of lung cancer care: an interdisciplinary approach”

Editorial preface to this special issue “Improving the quality and outcomes of lung cancer care: an interdisciplinary approach”

Por Osarogiagbon, Raymond U.
Publicado no Transl Lung Cancer Res (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

333

B-RAF mutation in non-small cell lung cancer: the sleeping beauty is waking up

B-RAF mutation in non-small cell lung cancer: the sleeping beauty is waking up

Por Rolfo, Christian, Caparica, Rafael
Publicado no Transl Lung Cancer Res (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

334

Pembrolizumab as first-line treatment for non-small cell lung cancer—a game changer?

Pembrolizumab as first-line treatment for non-small cell lung cancer—a game changer?

Por Dempke, Wolfram C. M., Fenchel, Klaus
Publicado no Transl Lung Cancer Res (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

335

Preface on “Emerging treatment options for brain metastases from non-small cell lung cancer”

Preface on “Emerging treatment options for brain metastases from non-small cell lung cancer”

Por Metro, Giulio, Chiari, Rita
Publicado no Transl Lung Cancer Res (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

336

Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

Por Liam, Chong-Kin
Publicado no Transl Lung Cancer Res (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

337

Identification of a novel therapeutic target in driver-negative non-small cell lung cancer

Identification of a novel therapeutic target in driver-negative non-small cell lung cancer

Por Saito, Motonobu, Kono, Koji, Kohno, Takashi
Publicado no Transl Lung Cancer Res (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

338

Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy

Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapy

Por Verma, Vivek, Chang, Joe Y.
Publicado no Transl Lung Cancer Res (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

339

Histology versus cytology: PD-L1 testing in non-small cell lung cancer

Histology versus cytology: PD-L1 testing in non-small cell lung cancer

Por Takigawa, Nagio, Ochi, Nobuaki, Yamane, Hiromichi
Publicado no Transl Lung Cancer Res (2018)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

340

A strong step forward in maintenance therapy for non-small cell lung cancer treatment

A strong step forward in maintenance therapy for non-small cell lung cancer treatment

Por Santos, Edgardo S., Mekhail, Tarek
Publicado no Transl Lung Cancer Res (2012)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

[1]
Anterior
12
13
14
15
16
17
18
19
20
21
22
Seguinte
[46]